Vijay Jayaprakash

Vijay Jayaprakash

Program Leader, Immuno Oncology, Oncology Clinical Development @ Bristol Myers Squibb

About Vijay Jayaprakash

Vijay Jayaprakash is the Program Leader for Immuno-oncology in Oncology Clinical Development at Bristol-myers Squibb, with extensive experience in oncology research and clinical trials.

Title at Bristol-myers Squibb

Vijay Jayaprakash currently holds the position of Program Leader in Immuno Oncology within the Oncology Clinical Development team at Bristol-myers Squibb, located in New Jersey, United States.

Previous Roles at Bristol-myers Squibb

In 2017, Vijay Jayaprakash served as a Clinical Trial Lead for Immuno Oncology in the Oncology Clinical Development division at Bristol-myers Squibb, also based in New Jersey, United States. This role lasted for 5 months.

Experience at Astrazeneca

Between 2015 and 2017, Vijay Jayaprakash was a Medical Scientist in Immuno-oncology within the Global Medicines Development team at Astrazeneca, located in Cambridge, Cambridgeshire, United Kingdom. Prior to that, from 2014 to 2015, he worked as a Medical Evidence Leader in Global Medical Affairs at the same company.

Academic Positions at Roswell Park Cancer Institute

From 2012 to 2014, Vijay Jayaprakash held the position of Assistant Professor of Oncology in the Department of Head and Neck Surgery at Roswell Park Cancer Institute, Buffalo, New York. Additionally, he served as an Assistant Professor in Cancer Pathology and Prevention from 2013 to 2014 at the same institution.

Educational Background

Vijay Jayaprakash earned a Doctor of Philosophy (PhD) in Epidemiology from the University at Buffalo, concluding his studies in 2008. He also obtained a Doctor of Medicine (MD) from Tamil Nadu Doctor M.G.R. Medical University, completing the program in 2002. Additionally, he studied Economics at the University of Washington during the 2013-2014 academic year.

Research and Publications

Vijay Jayaprakash has published over 20 peer-reviewed articles in leading oncology journals. His research led to the development of a novel biomarker for the early detection of aerodigestive cancers. He has also secured over $5 million in research grants for studies focused on cancer prevention and treatment.

Awards and Recognitions

In 2016, Vijay Jayaprakash received the 'Excellence in Clinical Research' award from the American Association for Cancer Research. He was also a keynote speaker at the International Conference on Clinical Trials in Oncology in 2018.

Community Involvement and Mentorship

Vijay Jayaprakash has actively participated in community outreach programs focused on cancer awareness and prevention, targeting underserved populations. Additionally, he has mentored over 15 PhD students and postdoctoral fellows in the fields of oncology and clinical epidemiology.

People similar to Vijay Jayaprakash